Get the Stockscreener App
0.6251
16.56%
-0.1241
After Hours:
.64
0.0149
+2.38%
Cdt Equity Inc stock is traded at $0.6251, with a volume of 720.25K.
It is down -16.56% in the last 24 hours and down -80.09% over the past month.
CDT Equity Inc is a data-driven biopharmaceutical development company focused on identifying, enhancing, and advancing high-potential therapeutic assets through scientific innovation and strategic partnerships. It has evolved into a broader, more agile platform that leverages artificial intelligence, solid-form chemistry, and efficient asset repositioning to accelerate the development of novel treatments. The company's pipeline includes candidates that target autoimmune disorders, as well as idiopathic male infertility, oncology, dermatology, rare disease and animal health. It has one operating segment focused on the research and development of clinical assets.
See More
Previous Close:
$0.7492
Open:
$0.73
24h Volume:
720.25K
Relative Volume:
1.03
Market Cap:
$491.75K
Revenue:
-
Net Income/Loss:
$-39.62M
P/E Ratio:
-0.000378
EPS:
-1654.3275
Net Cash Flow:
$-17.96M
1W Performance:
-63.01%
1M Performance:
-80.09%
6M Performance:
-99.65%
1Y Performance:
-99.97%
1-Day Range:
$0.612
$0.745
1-Week Range:
$0.612
$1.79
52-Week Range:
$0.612
$2,440.00
Cdt Equity Inc Stock (CDT) Company Profile
Name
Cdt Equity Inc
Sector
Industry
Phone
(646) 491 9132
Address
4851 TAMIAMI TRAIL NORTH, NAPLES
Compare CDT vs VRTX, REGN, ARGX, MRNA, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CDT
Cdt Equity Inc
|
0.6251 | 2.28M | 0 | -39.62M | -17.96M | -1,654.33 |
VRTX
Vertex Pharmaceuticals Inc
|
546.12 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
827.72 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,033.15 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
145.55 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
210.02 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
Cdt Equity Inc Stock (CDT) Latest News
CDTG Stock Jumps After Sharp Intraday Reversal - timothysykes.com
CDTG Stock Jumps After Volatile Intraday Spike - StocksToTrade
CDT Equity Amends Sarborg Deal, Manages Convertible Financing - TipRanks
CDT Equity Amends $8 Million Sarborg Investment and Adds $542K Convertible Note, Later Repaid - TradingView
CDT Equity Inc. announced that it has received $1.46 million in funding from J.J. Astor & Co. - marketscreener.com
These stocks are moving in today's after hours session - ChartMill
Corvus Capital's Activist Stake in CDT Equity (NASDAQ: CDT) Reaches 43.7% - Kalkine Media
Corvus Capital Converts CDT Equity (NASDAQ: CDT) Warrants into 5.44 Million Common Shares, Holding 43.7% Stake - Kalkine Media
Cdt equity CEO Andrew Regan’s entity acquires shares, disposes of 290 - Investing.com
Nearly 10% of CDT Equity Inc. (CDT) is reported in one shareholder group’s hands - Stock Titan
[Form 4] CDT Equity Inc. Insider Trading Activity - Stock Titan
[SCHEDULE 13D/A] CDT Equity Inc. Amended Major Shareholder Report - Stock Titan
CDT Equity Share Issuance Boosts Nasdaq Compliance Status - theglobeandmail.com
Dow Surges Over 200 Points; Ollie's Bargain Outlet Shares Gain After Q2 Earnings - Benzinga
CDT Equity (NASDAQ: CDT) Achieves $23 Million Market Cap Following Full Warrant Conversion - Kalkine Media
CDT Equity Names James Bligh CEO Amid Leadership Shift - theglobeandmail.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
CDT Equity Inc. Reports 13.7 Million Shares Outstanding and Nasdaq Compliance - Quiver Quantitative
CDT Provides Capital Update and Confirms No Nasdaq Deficiencies - WBOC TV
CDT Equity (CDT) Shares Fall 21% After Hours: Here's What Happened - Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
James Bligh Appointed CEO of CDT Equity (NASDAQ: CDT) Starting August 31 with $600,000 Salary - Kalkine Media
CDT Appoints Co-Founder James Bligh as Chief Executive Officer to Lead Next Phase of Growth - The Manila Times
CDT Equity appoints James Bligh as CEO; Andrew Regan resigns - TradingView
CDT Equity names CEO, gets reverse split approval - Stock Titan
CDT Equity Inc. Announces Appointment of James Bligh to Chief Executive Officer - marketscreener.com
CDT Validates Enhanced Solid-Form Properties within Its IP Portfolio - marketscreener.com
CDT Validates Enhanced Solid-Form Properties Within Its IP Portfolio - The Manila Times
CDT Equity Inc. Announces New Patent-Protected Solid Forms and AI-Identified Uses for Existing Drug Compounds - Quiver Quantitative
CDT's new drug-compound forms show improved stability and solubility - Stock Titan
CDT (CDT) Results Review: The Company Publishes Its Latest Results on the Day; Stock Move: The Stock Ends Down 18.32% in the Available RecordEarnings Beat Streak - dars.gov.et
Pep?d Inc. announced that it has received funding from CDT Equity Inc. - marketscreener.com
CDT Announces Investment in Pep'd, Expanding into the Fast-Growing US Peptide Market - The Manila Times
The global peptide therapeutics market is projected to reach $294.6B by 2033; CDT invests in Pep'd - Stock Titan
Enterprise value to revenue forward of CDT Equity Inc. – NASDAQ:CDTTW - TradingView
Passive 2.97% stake by investor group in CDT Equity (CDT) - Stock Titan
New 5.3% passive stake surfaces in CDT Equity Inc. (CDT) - Stock Titan
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
CDT Equity (CDT) Sarborg losses, $65M patents and going‑concern doubts - Stock Titan
CDT | CDT Equity Inc. Common Executive Compensation - Quiver Quantitative
CDT Equity Inc. Q2 2026: Net loss $(4.64M), EPS $(8.71) — 10-Q Summary - TradingView
CDT Equity Inc. (CDT) flags going concern risk despite Sarborg investment gain - Stock Titan
CDT Equity Inc. Warrant (CDTTW) Holds Steady at $0.01 Amidst Quiet TradingSymmetrical Triangle - dars.gov.et
CDT Equity Inc. SEC Filing (Aug 11, 2026) - Stock Titan
CDT Equity Expands Convertible Note and Equity Financing - The Globe and Mail
CDT Equity Inc. (Nasdaq: CDT) lifts note to $2,536,650, adds warrants - Stock Titan
CDT Equity Inc. Revenue Breakdown – BOATS:CDTTW - TradingView
CDT Equity to Boost Stake in Sarborg - marketscreener.com
Press Release: CDT Increases Stake in Sarborg Following Its Quantum Computing and Intellectual Property Expansion - 富途牛牛
CDT Increases Stake in Sarborg following its Quantum Computing and Intellectual Property Expansion - The Manila Times
CDT Equity Inc. agreed to acquire 22.70% stake in Sarborg Limited. - marketscreener.com
Cdt Equity Inc Stock (CDT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.86%
0.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):